Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ABC Transporter-Mediated Multidrug-Resistant Cancer
Haneen Amawi, Hong‐May Sim, Amit K. Tiwari, et al.
Advances in experimental medicine and biology (2019), pp. 549-580
Closed Access | Times Cited: 195

Showing 26-50 of 195 citing articles:

Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy
Yuan Ma, Sifan Yu, Shuaijian Ni, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 41
The role of endolysosomal trafficking in anticancer drug resistance
Noor Hussein, Saloni Malla, Mariah A. Pasternak, et al.
Drug Resistance Updates (2021) Vol. 57, pp. 100769-100769
Open Access | Times Cited: 41
Role of Globotriaosylceramide in Physiology and Pathology
Ana Celi, Jorge Goldstein, María Victoria Rosato‐Siri, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 30
Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy
Wenjing Xu, Chunping Ye, Qing Xin, et al.
Materials Today Bio (2022) Vol. 16, pp. 100358-100358
Open Access | Times Cited: 28
Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2
Chung‐Pu Wu, Sung-Han Hsiao, Yu‐Shan Wu
Drug Resistance Updates (2023) Vol. 71, pp. 101011-101011
Closed Access | Times Cited: 21
Evaluation of the FDA-approved kinase inhibitors to uncover the potential repurposing candidates targeting ABC transporters in multidrug-resistant cancer cells: an in silico approach
Alireza Poustforoosh, Fatemeh Moosavi
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-13
Closed Access | Times Cited: 20
Erianin: A phytoestrogen with therapeutic potential
Gangmin Li, Huiqiong Zhang, Hui Lai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
Identification and characterization of endogenous biomarkers for hepatic vectorial transport (OATP1B3-P-gp) function using metabolomics with serum pharmacology
Yong-wen Jin, Yanrong Ma, Mingkang Zhang, et al.
Amino Acids (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 6
Co-delivery of siBcl-2 and PTX with mitochondria-targeted functions to overcoming multidrug resistance
Liqiao Zhang, Xinyu Cao, Jiayi Chen, et al.
International Journal of Pharmaceutics (2024) Vol. 654, pp. 123970-123970
Closed Access | Times Cited: 6
Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study
Jiaming Gao, Jingwen Cheng, Wanyu Xie, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 639-651
Closed Access | Times Cited: 6
Cancer stem cells in colorectal cancer and the association with chemotherapy resistance
Lei Xue, Qinglian He, Ziqi Li, et al.
Medical Oncology (2021) Vol. 38, Iss. 4
Closed Access | Times Cited: 36
Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells
Vrinda Gote, Amar Deep Sharma, Dhananjay Pal
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1257-1257
Open Access | Times Cited: 33
Nanomedicines for Overcoming Cancer Drug Resistance
Tingting Hu, Hanlin Gong, Jiayue Xu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1606-1606
Open Access | Times Cited: 27
Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells
Chenmala Karthika, R. Sureshkumar, Mehrukh Zehravi, et al.
Life (2022) Vol. 12, Iss. 6, pp. 811-811
Open Access | Times Cited: 24
Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents
Disha Shah, M. Ajazuddin, Sankha Bhattacharya
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 1, pp. 367-391
Closed Access | Times Cited: 24
Imidazo[1,2-a]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance
Hui Li, Shenglie Zhang, Yan-Han Jia, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2804-2831
Closed Access | Times Cited: 15
Natural Inhibitors of P-glycoprotein in Acute Myeloid Leukemia
Manuela Labbozzetta, Paola Poma, Monica Notarbartolo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4140-4140
Open Access | Times Cited: 14
MiRNAs: main players of cancer drug resistance target ABC transporters
Forogh Mohammadi, Masoumeh Nejatollahi, Farhad Sheikhnia, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Recent advances in the role of circRNA in cisplatin resistance in tumors
Jiawen Zhang, Qiwen Yu, Weijin Zhu, et al.
Cancer Gene Therapy (2025)
Closed Access
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells
Jingqiu Wang, Dong‐Hua Yang, Yuqi Yang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1387-1387
Open Access | Times Cited: 34
ABC Transporters in T Cell-Mediated Physiological and Pathological Immune Responses
Christoph Thurm, Burkhart Schraven, Sascha Kahlfuß
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9186-9186
Open Access | Times Cited: 32
Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?
Dirk Theile, Pauline Wizgall
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 8, pp. 1621-1632
Open Access | Times Cited: 29
Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model
Marta Nowacka, Barbara Ginter-Matuszewska, Monika Świerczewska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3036-3036
Open Access | Times Cited: 21
Advances in Hydrogel-Based Microfluidic Blood–Brain-Barrier Models in Oncology Research
Ankur Sood, Anuj Kumar, Atul Dev, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 993-993
Open Access | Times Cited: 20
The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discovery
Benoit Cox, Johan Nicolaï, Beth Williamson
Biopharmaceutics & Drug Disposition (2022) Vol. 44, Iss. 1, pp. 113-126
Closed Access | Times Cited: 20

Scroll to top